Title: Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Authors: van der Graaf, Winette T A ×
Blay, Jean-Yves
Chawla, Sant P
Kim, Dong-Wan
Bui-Nguyen, Binh
Casali, Paolo G
Schöffski, Patrick
Aglietta, Massimo
Staddon, Arthur P
Beppu, Yasuo
Le Cesne, Axel
Gelderblom, Hans
Judson, Ian R
Araki, Nobuhito
Ouali, Monia
Marreaud, Sandrine
Hodge, Rachel
Dewji, Mohammed R
Coens, Corneel
Demetri, George D
Fletcher, Christopher D
Dei Tos, Angelo Paolo
Hohenberger, Peter
EORTC Soft Tissue and Bone Sarcoma Group
PALETTE study group #
Issue Date: May-2012
Publisher: The Lancet Publishing Group
Series Title: The Lancet vol:379 issue:9829 pages:1879-1886
Abstract: Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-agent activity in patients with advanced non-adipocytic soft-tissue sarcoma. We investigated the effect of pazopanib on progression-free survival in patients with metastatic non-adipocytic soft-tissue sarcoma after failure of standard chemotherapy.
ISSN: 0140-6736
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Experimental Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science